Advertisement
Screener

NEURAXIS, INC. (NRXS) EBITDA

NEURAXIS, INC. (NRXS) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income -$2.12M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA (m); Operating income -$1.74M; Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$2.08M*; Operating income -$2.10M; Depreciation and amortization $16.20K*.
  • 2025-06-30: Basis Reported; EBITDA -$1.70M*; Operating income -$1.72M; Depreciation and amortization $12.88K*.

Complete source-backed ebitda history.

Available history
2022-12-31 to 2025-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)-$2.12M(m)$1.93M(m)(m)-$1.03M*$272.57K$274.34K(m)(m)
2026-03-31Reported(m)-$1.74M(m)$1.61M(m)(m)-$1.23M$218.37K$99.57K(m)(m)
2025-09-30Reported-$2.08M*-$2.10M$16.20K*$811.41K-256.82%*$0.00*-$1.43M*$135.49K$130.85K(m)(m)
2025-06-30Reported-$1.70M*-$1.72M$12.88K*$894.09K-190.69%*$7.29K*-$1.47M*$146.64K$115.20K(m)(m)
2025-03-31Reported-$2.29M(m)(m)(m)-255.54%$18.00K-$1.60M$139.47K$117.87K(m)(m)
2024-12-31Reported-$1.46M(m)(m)(m)-191.78%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$1.64M*-$1.65M$9.27K*$666.63K-246.32%*$4.37K*-$1.39M*$97.05K$126.25K(m)(m)
2024-06-30Reported-$2.20M*-$2.21M$10.97K*$611.50K-359.09%*$8.69K*-$1.62M*$73.46K$54.31K(m)(m)
2024-03-31Reported-$1.82M(m)(m)(m)-281.67%$14.72K-$1.33M$75.08K$5.57K(m)(m)
2023-12-31Reported-$1.61M(m)(m)(m)-303.46%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$3.01M*-$3.02M$10.23K*$477.46K-630.86%*$2.67K*-$2.82M*$67.29K$44.95K(m)(m)
2023-06-30Reported-$1.11M*-$1.12M$10.21K*$646.02K-171.41%*$4.46K*-$625.23K*$67.81K$109.79K(m)(m)
2023-03-31Reported-$886,425.00(m)(m)(m)-110.10%$7.61K-$622.91K$95.90K$16.80K(m)(m)
2022-12-31Reported-$974,140.00(m)(m)(m)-158.89%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$1.19M*-$1.20M$8.35K*$618.80K-193.08%*(m)-$911.79K*$67.64K$86.17K(m)(m)
2022-06-30Reported(m)-$669.58K(m)$682.58K(m)(m)(m)$79.01K$13.66K(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported(m)-$7.83M(m)$3.57M(m)$31.15K-$6.43M$562.92K$493.61K(m)(m)
2024-12-31Reported-$7.12M(m)(m)(m)-265.05%$27.78K-$6.10M$362.00K$433.61K(m)(m)
2023-12-31Reported-$6.62M(m)(m)(m)-269.25%$30.78K-$6.69M$303.35K$169.31K(m)(m)
2022-12-31Reported-$3.34M(m)(m)(m)-124.22%$1.39K-$2.30M$297.06K$225.61K(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
electroCore, Inc. (ECOR)United States$0.102B
Streamex Corp. (STEX)United States$0.089B-0.19
Vivani Medical, Inc. (VANI)United States$0.111B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B